Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Canine Mammary Tumours (CMTs) exploit mitochondrial cholesterol for aggressive reprogramming.
Liana Hardy1, Brindha Kannan2, Manuel Rigon2
1Department of Comparative Biomedical Sciences, The Royal Veterinary College, University of London, Royal College Street, London NW01 TU, United Kingdom.
The mitochondrial translocator protein (TSPO) promotes canine mammary tumor (CMT) aggressiveness and Tamoxifen resistance by facilitating cholesterol handling. Targeting TSPO may improve cancer therapies and diagnostics.
Area of Science:
- Oncology
- Molecular Biology
- Veterinary Medicine
Background:
- Mitochondrial translocator protein (TSPO) is crucial for pro-survival in human breast cancer via Nucleus Associated Mitochondria (NAM).
- TSPO's role in Canine Mammary Tumours (CMTs) and its association with therapeutic resistance are not fully understood.
Purpose of the Study:
- To investigate the association of TSPO with CMT aggressiveness and reprogramming.
- To explore TSPO's role in endocrine therapy (ET) resistance and its potential as a therapeutic target.
Main Methods:
- Analysis of TSPO expression in CMT tissues and cells.
- Investigating TSPO's role in cellular reprogramming under oestrogen deprivation and Tamoxifen exposure.
- Assessing the impact of TSPO repression on NF-kB signaling in aggressive CMT cells.
Main Results:
- TSPO expression positively correlates with CMT aggressiveness.
- Upregulated TSPO in reprogrammed CMT cells reduces susceptibility to Tamoxifen by facilitating mitochondrial cholesterol handling.
- TSPO repression impairs the NF-kB pathway, confirming its pro-survival role.
Conclusions:
- Mitochondrial cholesterol handling mediated by TSPO is a key mechanism in aggressive CMT reprogramming.
- TSPO represents a potential biomarker and therapeutic target for improving diagnostics and treatment strategies for CMTs.
More Related Videos
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Animal Mitochondrial Genetics
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...